Any CEO worth his or her weight as a successful CE
Post# of 154009
(Total Views: 418)
Posted On: 07/01/2021 11:57:46 PM
Any CEO worth his or her weight as a successful CEO will tell you that it’s not them that made the company successful. They will say that they hired the right people. No Successful CEO will take all the credit. So it’s not all about leadership its more about people skills to me. Leadership is what I would say is the lesser of the two that are both important.
Hiring the right people for the job or to recognize that you hired the wrong person and sever the relationship and move on is leadership that I admire. I would say Nader possesses the skill to let someone go when expectations are not met. Some of this may be Dr. Kelly also or both of them deciding. Dr. Kelly has taken on the duties of hiring the right people and frankly he has done a good job so far and they recognized that we were spinning our wheels with some employees and let those people go. This is quality leadership. I feel Dr Kelly is doing a great job of hiring people now since Nader relinquished those duties to him. Dr. Recknor is a gem and it seems like we have a lot to learn about him yet.
I just hate the fact that if we were to overhaul the BOD and the management we might be shooting ourselves in the foot. We are pressed for time and dilution is our only saving grace. I don’t want dilution and neither does Nader. It will cost us way more dilution for a new group to come in and get up to speed. We are talking months or maybe even a year. That would be terrible and we are on a timeline for Covid indications. There will be a reduced market and it will only last a few short years. Granted we may pull other indications like fatigue syndrome out of these trials also so there is some long term benefits possible. It’s a big risk to change management in a dissolving covid market when we have so much time and effort and money invested in these indications and an unknown time it will take for a new management to get up to speed on everything. Sometimes there isn’t a right time but I would say this is a poor time to make a big change.
I have to say that we are already a billion dollar company and close to being a multi billion dollar company. One approval of any kind will get us that. So Nader will get us there. Last year Nader said he was tired and wanting to step back. I believe once Nader see’s that we crossed a finish line that his goal was met and that will be his time to step back and maybe just become a board member. That’s the vibe I was getting from him a year ago. Looks like Dr. Kelly might be his replacement or maybe they do a National search for a new CEO. Dr. Kelly might not want that position. Somehow you have everyone critiquing your decisions. Tough position for anyone.
Hiring the right people for the job or to recognize that you hired the wrong person and sever the relationship and move on is leadership that I admire. I would say Nader possesses the skill to let someone go when expectations are not met. Some of this may be Dr. Kelly also or both of them deciding. Dr. Kelly has taken on the duties of hiring the right people and frankly he has done a good job so far and they recognized that we were spinning our wheels with some employees and let those people go. This is quality leadership. I feel Dr Kelly is doing a great job of hiring people now since Nader relinquished those duties to him. Dr. Recknor is a gem and it seems like we have a lot to learn about him yet.
I just hate the fact that if we were to overhaul the BOD and the management we might be shooting ourselves in the foot. We are pressed for time and dilution is our only saving grace. I don’t want dilution and neither does Nader. It will cost us way more dilution for a new group to come in and get up to speed. We are talking months or maybe even a year. That would be terrible and we are on a timeline for Covid indications. There will be a reduced market and it will only last a few short years. Granted we may pull other indications like fatigue syndrome out of these trials also so there is some long term benefits possible. It’s a big risk to change management in a dissolving covid market when we have so much time and effort and money invested in these indications and an unknown time it will take for a new management to get up to speed on everything. Sometimes there isn’t a right time but I would say this is a poor time to make a big change.
I have to say that we are already a billion dollar company and close to being a multi billion dollar company. One approval of any kind will get us that. So Nader will get us there. Last year Nader said he was tired and wanting to step back. I believe once Nader see’s that we crossed a finish line that his goal was met and that will be his time to step back and maybe just become a board member. That’s the vibe I was getting from him a year ago. Looks like Dr. Kelly might be his replacement or maybe they do a National search for a new CEO. Dr. Kelly might not want that position. Somehow you have everyone critiquing your decisions. Tough position for anyone.
(5)
(0)